User profiles for Nicholas A. Veldhuis
Nicholas VeldhuisMonash University Verified email at monash.edu Cited by 2784 |
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
Typically considered to be cell surface sensors of extracellular signals, heterotrimeric GTP-binding
protein (G protein)–coupled receptors (GPCRs) control many pathophysiological …
protein (G protein)–coupled receptors (GPCRs) control many pathophysiological …
[HTML][HTML] Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4
Serine proteases such as trypsin and mast cell tryptase cleave protease-activated receptor-2
(PAR 2 ) at R 36 ↓S 37 and reveal a tethered ligand that excites nociceptors, causing …
(PAR 2 ) at R 36 ↓S 37 and reveal a tethered ligand that excites nociceptors, causing …
[PDF][PDF] G protein-coupled receptors: dynamic machines for signaling pain and itch
G protein-coupled receptors (GPCRs) are the major class of sensory proteins and a primary
therapeutic target in the pathways to pain and itch. GPCRs are complex signaling machines. …
therapeutic target in the pathways to pain and itch. GPCRs are complex signaling machines. …
The G protein–coupled receptor–transient receptor potential channel axis: molecular insights for targeting disorders of sensation and inflammation
Sensory nerves are equipped with receptors and ion channels that allow them to detect and
respond to diverse chemical, mechanical, and thermal stimuli. These sensory proteins …
respond to diverse chemical, mechanical, and thermal stimuli. These sensory proteins …
[HTML][HTML] Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory …
DP Poole, S Amadesi, NA Veldhuis… - Journal of biological …, 2013 - ASBMB
G protein-coupled receptors of nociceptive neurons can sensitize transient receptor
potential (TRP) ion channels, which amplify neurogenic inflammation and pain. Protease-activated …
potential (TRP) ion channels, which amplify neurogenic inflammation and pain. Protease-activated …
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
G protein-coupled receptors (GPCRs) are considered to function primarily at the plasma
membrane, where they interact with extracellular ligands and couple to G proteins that transmit …
membrane, where they interact with extracellular ligands and couple to G proteins that transmit …
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
Once activated at the surface of cells, G protein-coupled receptors (GPCRs) redistribute to
endosomes, where they can continue to signal. Whether GPCRs in endosomes generate …
endosomes, where they can continue to signal. Whether GPCRs in endosomes generate …
Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome
N Cenac, T Bautzova, P Le Faouder, NA Veldhuis… - Gastroenterology, 2015 - Elsevier
… Author links open overlay panel Nicolas Cenac 1 2 3 , Tereza Bautzova 1 2 3 , Pauline
Le Faouder 1 2 3 4 5 , Nicholas A. Veldhuis 6 , Daniel P. Poole 6 7 , Corinne Rolland 1 2 3 , …
Le Faouder 1 2 3 4 5 , Nicholas A. Veldhuis 6 , Daniel P. Poole 6 7 , Corinne Rolland 1 2 3 , …
Selective G protein signaling driven by substance P–neurokinin receptor dynamics
The neuropeptide substance P (SP) is important in pain and inflammation. SP activates the
neurokinin-1 receptor (NK1R) to signal via G q and G s proteins. Neurokinin A also activates …
neurokinin-1 receptor (NK1R) to signal via G q and G s proteins. Neurokinin A also activates …
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain
Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because
of the endosomal transport mechanisms of many nanomedicines within cells. Here, we …
of the endosomal transport mechanisms of many nanomedicines within cells. Here, we …